PRKAA1 predicts prognosis and is associated with immune characteristics in gastric cancer
Authors:
- 24 July 2023
- journal article
- research article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 23 (3) , 1-10
Abstract
PRKAA1 is the α-subunit of 5-AMP-activated protein kinase. This study aimed to investigate the role of PRKAA1 expression with multiple clinical parameters, the overall survival rate, blood indexes, and immune infiltration in gastric cancer (GC) patients. We investigated PRKAA1 expression data in GC patients using ELISA, protein atlas, UALCAN, and GEPIA. PRKAA1 expression was associated with immune cell infiltration, and immune cell types were analyzed with the TIMER, DICE, and protein atlas databases. We compared the level of PRKAA1 expression based on the clinical features of GC patients (n = 345). GC patients were divided into two groups based on PRKAA1 expression, and the lymphocyte subsets, overall survival rate, and clinical parameters were compared with peripheral blood mononuclear cell and biochemical indexes. PRKAA1 was highly expressed in the serum of GC patients compared with that of healthy individuals. GC patients with distant metastases, a later TNM stage, and stage IV in UICC exhibited higher PRKAA1 expression. PRKAA1 expression was significantly correlated with circulating T cells. The protein atlas and DICE database results confirmed that PRKAA1 was closely associated with T cells in a single-cell cluster. Furthermore, GC patients with low PRKAA1 expression had better OS rates. PRKAA1 may serve as a potential prognostic biomarker for GC and have an association with immune infiltrates.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2Molecular Cancer Research, 2016
- Aging of immune system: immune signature from peripheral blood lymphocyte subsets in 1068 healthy adultsAging, 2016
- PRKAA1/AMPKα1 is required for autophagy-dependent mitochondrial clearance during erythrocyte maturationAutophagy, 2014
- AMP kinase (PRKAA1)Journal of Clinical Pathology, 2014
- Genetic Variations in STK11, PRKAA1, and TSC1 Associated with Prognosis for Patients with Colorectal CancerAnnals of Surgical Oncology, 2014
- Peritoneal carcinomatosis of gastric origin: A population‐based study on incidence, survival and risk factorsInternational Journal of Cancer, 2013
- α-SNAP inhibits AMPK signaling to reduce mitochondrial biogenesis and dephosphorylates Thr172 in AMPKα in vitroNature Communications, 2013
- Impact of Tumor Progression on Cancer Incidence CurvesCancer Research, 2013
- Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer – Differential treatment strategies for subtypes of early gastroesophageal cancerEuropean Journal of Cancer, 2012
- The regulation of AMP-activated protein kinase by upstream kinasesInternational Journal of Obesity, 2008